These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7945221)

  • 1. Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes.
    Moola ZB; Scawen MD; Atkinson T; Nicholls DJ
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):921-7. PubMed ID: 7945221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase.
    Aghaiypour K; Wlodawer A; Lubkowski J
    Biochemistry; 2001 May; 40(19):5655-64. PubMed ID: 11341830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization.
    Kotzia GA; Labrou NE
    J Biotechnol; 2007 Jan; 127(4):657-69. PubMed ID: 16984804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the antigenicity of E. coli L-asparaginase by mutational analysis.
    Jianhua C; Yujun W; Ruibo J; Min W; Wutong W
    Mol Biotechnol; 2006 May; 33(1):57-65. PubMed ID: 16691007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic resolution structure of Erwinia chrysanthemi L-asparaginase.
    Lubkowski J; Dauter M; Aghaiypour K; Wlodawer A; Dauter Z
    Acta Crystallogr D Biol Crystallogr; 2003 Jan; 59(Pt 1):84-92. PubMed ID: 12499544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of two highly homologous bacterial L-asparaginases: a case of enantiomorphic space groups.
    Jaskólski M; Kozak M; Lubkowski J; Palm G; Wlodawer A
    Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):369-77. PubMed ID: 11223513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A left-handed crossover involved in amidohydrolase catalysis. Crystal structure of Erwinia chrysanthemi L-asparaginase with bound L-aspartate.
    Miller M; Rao JK; Wlodawer A; Gribskov MR
    FEBS Lett; 1993 Aug; 328(3):275-9. PubMed ID: 8348975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Insight into Substrate Selectivity of Erwinia chrysanthemi L-asparaginase.
    Nguyen HA; Su Y; Lavie A
    Biochemistry; 2016 Mar; 55(8):1246-53. PubMed ID: 26855287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase.
    Kotzia GA; Labrou NE
    J Biotechnol; 2005 Oct; 119(4):309-23. PubMed ID: 15951039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico identification and characterization of antineoplastic asparaginase enzyme from endophytic bacteria.
    Zadeh Hosseingholi E; Neghabi N; Molavi G; Gheibi Hayat SM; Shahriarpour H
    IUBMB Life; 2020 May; 72(5):991-1000. PubMed ID: 31981306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-aspartylpeptides as substrates of L-asparaginases from Escherichia coli and Erwinia chrysanthemi.
    Kelo E; Noronkoski T; Stoineva IB; Petkov DD; Mononen I
    FEBS Lett; 2002 Sep; 528(1-3):130-2. PubMed ID: 12297292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A covalently bound catalytic intermediate in Escherichia coli asparaginase: crystal structure of a Thr-89-Val mutant.
    Palm GJ; Lubkowski J; Derst C; Schleper S; Röhm KH; Wlodawer A
    FEBS Lett; 1996 Jul; 390(2):211-6. PubMed ID: 8706862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the role of threonine and serine residues of E. coli asparaginase II by site-specific mutagenesis.
    Derst C; Henseling J; Röhm KH
    Protein Eng; 1992 Dec; 5(8):785-9. PubMed ID: 1287659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering thermal stability of L-asparaginase by in vitro directed evolution.
    Kotzia GA; Labrou NE
    FEBS J; 2009 Mar; 276(6):1750-61. PubMed ID: 19220855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
    Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
    BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzyme.
    Gervais D; Foote N
    Mol Biotechnol; 2014 Oct; 56(10):865-77. PubMed ID: 24870616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.
    Huerta-Saquero A; Evangelista-Martínez Z; Moreno-Enriquez A; Perez-Rueda E
    Bioengineered; 2013; 4(1):30-6. PubMed ID: 22895060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.
    Figueiredo L; Cole PD; Drachtman RA
    Expert Rev Hematol; 2016 Mar; 9(3):227-34. PubMed ID: 26765930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
    Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
    Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of the specific function of the conserved threonine triad responsible for human L-asparaginase autocleavage and substrate hydrolysis.
    Nomme J; Su Y; Lavie A
    J Mol Biol; 2014 Jun; 426(13):2471-85. PubMed ID: 24768817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.